dihydrostreptomycin 3'α,6-bisphosphate

(1R,2S,3S,4R,5S,6S)-2,4-dicarbamimidamido-3,6-dihydroxy-5-(phosphonooxy)cyclohexyl 5-deoxy-2-O-[2-deoxy-2-(methylamino)-α-L-glucopyranosyl]-3-C-[(phosphonooxy)methyl]-α-L-lyxofuranoside

ZDDYYKRGKUKSLN-TWBNDLJKSA-N CHEBI:17751 0 Reactome links 2 studies

Metabolite details

Identifier: ZDDYYKRGKUKSLN-TWBNDLJKSA-N
InChI Key: ZDDYYKRGKUKSLN-TWBNDLJKSA-N
IUPAC name: (1R,2S,3S,4R,5S,6S)-2,4-dicarbamimidamido-3,6-dihydroxy-5-(phosphonooxy)cyclohexyl 5-deoxy-2-O-[2-deoxy-2-(methylamino)-α-L-glucopyranosyl]-3-C-[(phosphonooxy)methyl]-α-L-lyxofuranoside
Preferred name: dihydrostreptomycin 3'α,6-bisphosphate
INN name: —
Synonym: Dihydrostreptomycin 3'alpha,6-bisphosphate
ChEBI: CHEBI:17751

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
Metabolic Responses of a Model Green Microalga Euglena gracilis to Different Environmental Stresses

Observed in differential profiles

Wild_type_vs_hfq
Control_vs_Paramycin